- Neoadjuvant hormonal therapy use and the risk of death in men with prostate cancer treated with brachytherapy who have no or at least a single risk factor for coronary artery diseaseAkash Nanda
Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL, USA Electronic address
Eur Urol 65:177-85. 2014..However, its effect in men with no or at least a single risk factor for CAD stratified by prostate cancer (PCa) aggressiveness is unknown...
- Cardiovascular comorbidity and mortality in men with prostate cancer treated with brachytherapy-based radiation with or without hormonal therapyAkash Nanda
Department of Radiation Oncology, MD Anderson Cancer Center Orlando, Orlando, Florida, USA
Int J Radiat Oncol Biol Phys 85:e209-15. 2013..To assess the impact of coronary artery disease (CAD) risk factors and sequelae on the risk of all-cause mortality (ACM) in men treated for prostate cancer (PC)...